Gallbladder’s clear cell renal carcinoma metastasis: A case report  by Castro Ruiz, Carolina et al.
GC
C
U
a
A
R
R
1
A
A
K
G
R
T
D
1
m
e
w
a
f
t
d
o
d
o
(
c
(
h
2
cCASE  REPORT  –  OPEN  ACCESS
International Journal of Surgery Case Reports 18 (2016) 48–51
Contents lists available at ScienceDirect
International  Journal  of  Surgery  Case  Reports
j ourna l h om epage: www.caserepor ts .com
allbladder’s  clear  cell  renal  carcinoma  metastasis:  A  case  report
arolina  Castro  Ruiz ∗,  Claudio  Pedrazzoli,  Stefano  Bonacini
hirurgia I a prevalente indirizzo Oncologico Ricostruttivo, Dipartimento Chirurgia Generale e Specialistiche, Arcispedale S. Maria Nuova, IRCCS, Viale
mberto I, 50, 42123 Reggio Emilia, Italy
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 5 August 2015
eceived in revised form
9 November 2015
ccepted 20 November 2015
vailable online 27 November 2015
eywords:
allbladder metastatic disease
enal cell carcinoma
reatment
iagnosis
a  b  s  t  r  a  c  t
INTRODUCTION:  Clear  cell  renal  cell  carcinoma  (ccRCC)  is well  known  for  its propensity  to  metasta-
size  to unusual  sites,  even  after  10 years.  Gallbladder  metastases  are  extremely  rare,  being found  in
approximately  0.6%  of  cases,  at autopsy.
CASE  PRESENTATION:  A 51-year-old  man  with  a history  of right  ccRCC  underwent  total  nephrectomy  with
extended  lymphadenectomy,  in  another  Hospital.  Three  years  later,  he  was  hospitalized  at  our  Hospital,
with  gallbladder  metastasis  detected  during  a follow-up  CT  scan.  At  clinical  examination,  the  patient
did  not  present  any  symptoms  or  signs  of gallbladder  disease.  Several  imaging  tests  were  performed  to
better characterize  the  lesion.  A  successful  cholecystectomy  and  hepatic  resection  of  4b segment  were
performed,  obtaining  a  R0  resection.  The  clinical  course  was uneventful,  without  any  complications.  After
a 7-month  follow-up,  the  patient  is free  from  disease.
DISCUSSION: A  typical  metastases  are  those  located  in a site  other  than  thoracic,  skeletal,  hepatic,  adrenal
or encephalic  tissue.  Cholecystectomy  with R0 resection  has demonstrated  to  be  the  only  factor  increasing
survival,  mainly  in isolated  cases  of  metastasis,  providing  an  overall  35–60%  survival  rate  at 5 years.
CONCLUSION:  In  the  follow-up  of  patients  with  a positive  history  of renal  cell carcinoma  specially  clear
cell  subtype,  all  new  ﬁnding  should  be  taken  into  account  as  possible  metastases.  We  ought  to  consider
US  and  CT-scan  behavior  of  gallbladder  metastatic  disease  in  order  to orientate  our diagnosis.  Surgery  for
metastatic gallbladder  disease  of  renal  origin  seems  to be a feasible  therapy  which  is  capable  of  increasing
patients’  overall  survival.
©  2015  The  Authors.  Published  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Kidney cancer accounts for approximately 2% of the total human
alignancies with approximately 190,000 new cases diagnosed
ach year world wide. Clear cell renal cell carcinoma (ccRCC) is
ell known for its propensity to metastasize to unusual sites, even
fter 10 years from diagnosis of primary lesion [1]. CcRCC accounts
or about 70% of renal cell carcinoma (RCC) and approximately one
hird of these patients commonly develop metastases [2]. Gallblad-
er metastasis is extremely rare, being found in approximately 0.6%
f cases, at autopsy [3]. In our paper, we report a case of gallblad-
er’s clear cell renal cell carcinoma metastasis and introduce an
verview of diagnostic imaging and treatment.
This paper has been reported in line with the CARE criteria
http://www.care-statement.org).∗ Corresponding author. Fax: +39 522 296266.
E-mail addresses: carolina.castroruiz85@gmail.com,
arolina.castroruiz@asmn.re.it (C. Castro Ruiz), claudio.pedrazzoli@asmn.re.it
C. Pedrazzoli), stefano.bonacini@asmn.re.it (S. Bonacini).
ttp://dx.doi.org/10.1016/j.ijscr.2015.11.021
210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2. Case report
We  present the case of a 51-year-old man with a history of
right ccRCC. In July 2011, he underwent total right nephrectomy
with extended lymphadenectomy. His specimen was  classiﬁed as
Führman pT2a N0 M0  grade 3, stage II. At that time, this pathology
was considered of low-medium risk, with no indication for fur-
ther therapy. During follow-up, in January 2013, a chest CT scan
showed two  pulmonary nodes (18 mm and 8 mm),  which were
treated with 7 cicles of bevacizumab and alfa 2-A interferon, and
later on with sunitinib. After a 8-month therapy, a control chest CT
scan was  performed, showing an important reduction of the pul-
monary nodes. In a further chest-abdomen CT scan performed in
October 2014, the pulmonary nodes were too small to be character-
ized, but a 13 mm × 11 mm  × 8 mm polyp lesion was found within
the gallbladder lumen. At clinical examination, the patient did not
present any symptoms or signs of gallbladder disease, such as
abdominal tenderness or jaundice. Laboratory tests did not detect
any alterations, and gave the following results: total bilirubin was
0.6 mg/dl (0.3–1.2 mg/dl), albumin was  4.28 g/dl (3.3–5.5 g/dl), AST
was 25 U/L (2–40 U/L), ALT was  21 U/L (4–49 U/L), ALP was 152 U/L
(70–290 U/L), GGT was  27 U/L (5–65 U/L) and LDH was 415 U/L
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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iFig. 1. Ultrasonography showing an hyperechoic mass within the gallbladder.
125–243 U/L). In the light of such ﬁndings, the patient underwent
everal imaging tests, in order to better deﬁne the lesion.
Within the gallbladder’s lumen (Fig. 1), ultrasonography
howed an hyperechoic 18 mm × 24 mm mass, without signiﬁcant
olor-doppler signal. Abdominal CT scan revealed the presence of
n hyperdense 3 cm mass located over the gallbladder, without
 clear dissection plane between this mass and the intra-luminal
ell known one (Fig. 2). Abdominal MRI  conﬁrmed a 18 mm solid
ode at the gallbladder’s fundus, that presented contrast enhance-
ent, with no signs of hepatic parenchyma inﬁltration. MRI  was
nable to identify the second mass previously detected by the CT
can (Fig. 3). In order to complete the pre-operatory work-up, we
equested a CEUS (contrast-enhanced ultrasonography) with the
se of Sonovue®: the lesion within the gallbladder presented arte-
ial enhancement and excluded hepatic involment. PET (Positron
mission Tomography) showed high radioactivity in the gallblad-
er area (Fig. 4).
After case assessment by our multidisciplinary team, the patient
nderwent open cholecystectomy with 4b segmental hepatic
esection; we performed an extemporaneous anatomopatholog-
cal examination of the gallbladder wall, resulting in renal cell
arcinoma metastasis. Our diagnosis was conﬁrmed by the ﬁnal
istological examination. The ﬁnal histological report deﬁned the
econd lesion (described at CT scan) as benign gallbladder adeno-
yomatosis in a setting of chronic cholecistitis with no hepatic
nﬁltration (Fig. 5).
Fig. 2. CT scan that conﬁrms the hyperdense mass.Fig. 3. MRI  showing the lesion located at the funus of the gallbladder.
Surgery was  successful, obtaining a R0 resection. The patient
resumed eating on the 4th postoperatory day and the drainage
tube was removed on the 8th postoperative day. The patient was
uneventfully discharged on the 11th postoperative day. After 7
months, he is still free from disease, he is in good general conditions
and undergoing follow-up at the oncological outpatient clinic.
3. Discussion
Renal cell carcinoma has a strong tendency to metastasize,
mainly due to a complex and rich vascularization and its lymphatic
drainage. The most common target organs are lungs (75%), bones
(20%), lymph nodes (11%), liver (18%), and brain (8%) [4]. Atypical
metastases are considered those located in a site other than tho-
racic, skeletal, hepatic, adrenal or encephalic regions [5]. Clear cell
renal cell carcinoma most commonly metastasize hematogenously,
via the vena cava, primarily to the lung, although lymphatic metas-
tasis also may  occur. Retrograde metastasis along the paravertebral
veins, the vena testicularis/vena ovarii, intra renal veins, or along
the ureter may  also occur [6].
In our case, the metastatic disease presented at the gallbladder,
which is a rather unusual metastatic area for ccRCC. Gallbladder
metastases secondary to ccRCC are exceptional events and the
world literature described only 41 such cases [3,4,6–10].
When gallbladder is affected by metastatic disease, it stems usu-
ally from melanoma, stomach, pancreas, ovary, small bowel, biliary
duct and breast carcinomas [11,12]. Choi et al. found that the most
common metastasis to the gallbladder was gastric cancer, followed
by renal cell carcinoma [13].
The average time between radical nephrectomy and the onset of
metastatic disease was  3.1 years, as stated by Leibovich et al. [14],
as it was our patient’s case.
Atypical metastases are an exceptional sign of metastatic renal
cell carcinoma, but the role of surgery in this case is similar to that of
surgery in pulmonary metastasis. In these cases, metastasectomy
is accepted as possible treatment and in atypical metastases the
cancer speciﬁc survival is similar [5].
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Due to low radiosensitivity, surgery is the preferred option if the
umor can be resected without unacceptable functional sequelae
15].
Gallbladder cancer patients can resemble those with chronic
holecystitis [16]. On the other hand, clinical ﬁndings are not spe-
iﬁc enough to obtain a ﬁnal diagnosis. Imaging may  not be able
o make a differential diagnosis between primary and secondary
umors of the gallbladder. US is the initial approach in the diagnosis
f gallbladder tumors; metastases larger than 1 cm in diameter can
ppear under different hyperechoic masses, close to the gallblad-
er wall, without posterior acoustic shadowing. In primary tumors,
ne could observe a solid mass occupying the whole wall thickness,
ig. 5. Hystological staining of the lesion, that diagnosed clear cell renal cell carci-
oma metastasis.ivity in the gallbladder area.
or a polypoid lesion with an increased blood ﬂow. A CT scan sig-
nal which could be of some help in differentiating between primary
and metastatic gallbladder tumors is represented by the invasion of
the mucosal layer; in case the mucosa is not inﬁltrated, indicating
an invasion from the serosa layer, the primary gallbladder tumor
can be excluded [11]. Doppler ultrasonography has been success-
ful in demostrating the vascularity of renal cell carcinoma in other
locations [17].
Furthermore, in contrast CT scan, metastases from ccRCC
are hypervascular, whereas primary gallbladder cancer does not
present an hypervascular pattern; another peculiarity is repre-
sented by the fact that gallstones do not usually accompany
metastatic gallbladder tumors from RCC, though primary cancer
often coexists with gallstones [3]. Metastatic renal cell carcinoma
tends to have a polypoid morphology instead of a cholecystic mass,
with early wash-in and wash-out [13]. It is important to know
whether we  face a primary gallbladder tumor or a metastatic dis-
ease, because of gallbladder cancer propensity for early metastasis
and direct invasion of the liver [18]. This might modify surgical
approach, requiring—if necessary—a much larger hepatic resection.
Cholecystectomy with R0 resection has proved to be the only
factor that increases survival, mainly in isolated cases of metastasis.
The latest case reports showed that solitary metastasis of renal cell
gallbladder carcinoma (with no evidence of involvement of other
anatomic sites) correlates with better survival [19]. In metastatic
gallbladder cancer, an R0 resection is the only factor associated
with prolonged survival. The presentation of the metastatic disease
with acute cholecystitis was associated to poor survival, because of
overall tumor metastasizing to the gallbladder [9].
Metastasectomy provided an overall 35–60% survival (OS) at
5 years in patients who underwent metastasectomy of a solitary
lesion, but its beneﬁt is highly correlated with the metastasis site.
It is important to keep in mind some good prognosis criteria,
that might help in selecting patients who  are supposed to bene-
ﬁt from surgery: metachronous metastasis with a recurrence-free
period longer than 12 months, solitary metastasis, good health
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ondition, and patients aged under 60 years [20]. It was  reported
hat a Fuhrman grading that increases between the primary tumor
nd the metastasis is detrimental [21].
At present, according to European Association of Urology guide-
ines, nephrectomy combined with alpha-IFN is recommended for
atients with metastatic renal cell carcinoma, who are suitable for
urgery and have a good performance status. In patients with syn-
hronous metastatic spread, metastasectomy should be performed
f the metastatic spread is resectable and the patient has a good
erformance status. Clinical prognosis is worse in patients who
nderwent surgery for metachronous metastasis [19].
. Conclusion
All new ﬁndings during follow-up in patients with a positive
istory of RCC (in particular clear cell subtype) should be consid-
red as possible metastases. We  have to consider US and CT-scan
ehavior of gallbladder metastatic disease, in order to orientate our
iagnosis. Metastatic gallbladder tumor is very difﬁcult to diagnose,
ecause it is easily mistaken with benign disease during common
maging. In a patient with positive history of RCC we  have to rule
ut any possible metastasis, before judging a gallbladder lesion as
enign. Up to date, surgery for metastatic gallbladder disease of
enal origin seems to be a feasible treatment, capable of increasing
atients’ overall survival.
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